{"entity":{"type":"insider","cik":"0001890678","url":"/insider/0001890678","json_url":"/insider/0001890678.json","name":"David P. Perry 2015 Trust","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":3,"first":"2021-11-01","last":"2023-04-12","span_basis":"filed_date"},"name_variants":[{"name":"David P. Perry 2015 Trust","source":"filing","n_filings":3,"first_seen":"2021-11-01","last_seen":"2023-04-12"}],"transactions":[{"id":8457581,"accession":"0000899243-23-011231","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-011231","line_url":"/filing/0000899243-23-011231","is_derivative":false,"issuer_cik":"0001105941","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001105941","owner_cik":null,"owner_name":"PERRY DAVID P; David P. Perry 2015 Trust","owner_display_name":"PERRY DAVID P","owner_url":null,"role":"Director, Officer, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4969697.0,"shares_display":"4,969,697","price_per_share":0.825,"price_display":"0.82","price_state":"stated","total_value":4100000.025,"total_display":"4,100,000.02","total_whole":"4,100,000","shares_owned_after":3636364.0,"shares_owned_after_display":"3,636,364","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-10","filed_date":"2023-04-12","scope":"insider","n_lines":2},{"id":6167462,"accession":"0000899243-22-031420","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-031420","line_url":"/filing/0000899243-22-031420#line-2","is_derivative":false,"issuer_cik":"0001105941","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001105941","owner_cik":null,"owner_name":"David P. Perry 2015 Trust; PERRY DAVID P","owner_display_name":"David P. Perry 2015 Trust","owner_url":null,"role":"Director, Officer, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":39156.0,"shares_display":"39,156","price_per_share":2.068,"price_display":"2.07","price_state":"stated","total_value":80974.608,"total_display":"80,974.61","total_whole":"80,975","shares_owned_after":101536.0,"shares_owned_after_display":"101,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-16","filed_date":"2022-09-19","scope":"insider"},{"id":6167458,"accession":"0000899243-22-031420","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-031420","line_url":"/filing/0000899243-22-031420#line-1","is_derivative":false,"issuer_cik":"0001105941","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001105941","owner_cik":null,"owner_name":"David P. Perry 2015 Trust; PERRY DAVID P","owner_display_name":"David P. Perry 2015 Trust","owner_url":null,"role":"Director, Officer, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10844.0,"shares_display":"10,844","price_per_share":1.994,"price_display":"1.99","price_state":"stated","total_value":21622.936,"total_display":"21,622.94","total_whole":"21,623","shares_owned_after":62380.0,"shares_owned_after_display":"62,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-19","scope":"insider"},{"id":4088347,"accession":"0000899243-21-042250","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-21-042250","line_url":"/filing/0000899243-21-042250#line-12","is_derivative":false,"issuer_cik":"0001105941","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001105941","owner_cik":null,"owner_name":"David P. Perry 2015 Trust; PERRY DAVID P","owner_display_name":"David P. Perry 2015 Trust","owner_url":null,"role":"Director, Officer, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":2000000.0,"total_display":"2,000,000.00","total_whole":"2,000,000","shares_owned_after":10730037.0,"shares_owned_after_display":"10,730,037","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-28","filed_date":"2021-11-01","scope":"insider"},{"id":4088321,"accession":"0000899243-21-042250","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-21-042250","line_url":"/filing/0000899243-21-042250#line-7","is_derivative":false,"issuer_cik":"0001105941","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001105941","owner_cik":null,"owner_name":"David P. Perry 2015 Trust; PERRY DAVID P","owner_display_name":"David P. Perry 2015 Trust","owner_url":null,"role":"Director, Officer, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":9.95,"price_display":"9.95","price_state":"stated","total_value":199000.0,"total_display":"199,000.00","total_whole":"199,000","shares_owned_after":51536.0,"shares_owned_after_display":"51,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-26","filed_date":"2021-11-01","scope":"insider"},{"id":4088318,"accession":"0000899243-21-042250","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-042250","line_url":"/filing/0000899243-21-042250#line-6","is_derivative":false,"issuer_cik":"0001105941","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001105941","owner_cik":null,"owner_name":"David P. Perry 2015 Trust; PERRY DAVID P","owner_display_name":"David P. Perry 2015 Trust","owner_url":null,"role":"Director, Officer, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":9.94,"price_display":"9.94","price_state":"stated","total_value":79520.0,"total_display":"79,520.00","total_whole":"79,520","shares_owned_after":31536.0,"shares_owned_after_display":"31,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-24","filed_date":"2021-11-01","scope":"insider"},{"id":4088315,"accession":"0000899243-21-042250","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-21-042250","line_url":"/filing/0000899243-21-042250#line-5","is_derivative":false,"issuer_cik":"0001105941","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001105941","owner_cik":null,"owner_name":"David P. Perry 2015 Trust; PERRY DAVID P","owner_display_name":"David P. Perry 2015 Trust","owner_url":null,"role":"Director, Officer, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":9.95,"price_display":"9.95","price_state":"stated","total_value":79600.0,"total_display":"79,600.00","total_whole":"79,600","shares_owned_after":23536.0,"shares_owned_after_display":"23,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-21","filed_date":"2021-11-01","scope":"insider"},{"id":4088312,"accession":"0000899243-21-042250","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-042250","line_url":"/filing/0000899243-21-042250#line-4","is_derivative":false,"issuer_cik":"0001105941","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001105941","owner_cik":null,"owner_name":"David P. Perry 2015 Trust; PERRY DAVID P","owner_display_name":"David P. Perry 2015 Trust","owner_url":null,"role":"Director, Officer, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3060.0,"shares_display":"3,060","price_per_share":9.93,"price_display":"9.93","price_state":"stated","total_value":30385.8,"total_display":"30,385.80","total_whole":"30,386","shares_owned_after":15536.0,"shares_owned_after_display":"15,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-11-01","scope":"insider"},{"id":4088308,"accession":"0000899243-21-042250","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-042250","line_url":"/filing/0000899243-21-042250#line-3","is_derivative":false,"issuer_cik":"0001105941","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001105941","owner_cik":null,"owner_name":"David P. Perry 2015 Trust; PERRY DAVID P","owner_display_name":"David P. Perry 2015 Trust","owner_url":null,"role":"Director, Officer, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":9.93,"price_display":"9.93","price_state":"stated","total_value":69510.0,"total_display":"69,510.00","total_whole":"69,510","shares_owned_after":12476.0,"shares_owned_after_display":"12,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-13","filed_date":"2021-11-01","scope":"insider"},{"id":4088304,"accession":"0000899243-21-042250","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-042250","line_url":"/filing/0000899243-21-042250#line-2","is_derivative":false,"issuer_cik":"0001105941","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001105941","owner_cik":null,"owner_name":"David P. Perry 2015 Trust; PERRY DAVID P","owner_display_name":"David P. Perry 2015 Trust","owner_url":null,"role":"Director, Officer, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3476.0,"shares_display":"3,476","price_per_share":9.93,"price_display":"9.93","price_state":"stated","total_value":34516.68,"total_display":"34,516.68","total_whole":"34,517","shares_owned_after":5476.0,"shares_owned_after_display":"5,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-11-01","scope":"insider"},{"id":4088295,"accession":"0000899243-21-042250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-042250","line_url":"/filing/0000899243-21-042250#line-1","is_derivative":false,"issuer_cik":"0001105941","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001105941","owner_cik":null,"owner_name":"David P. Perry 2015 Trust; PERRY DAVID P","owner_display_name":"David P. Perry 2015 Trust","owner_url":null,"role":"Director, Officer, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":9.95,"price_display":"9.95","price_state":"stated","total_value":19900.0,"total_display":"19,900.00","total_whole":"19,900","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-30","filed_date":"2021-11-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001832415","name":"Better Therapeutics, Inc.","url":"/issuer/0001832415","role":"Ten percent owner","n_filings":3,"first_seen":"2021-11-01","last_seen":"2023-04-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001890678","retrieved_at":"2026-08-24T17:03:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}